tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SUPN is currently covered by 1 analysts with an average price target of $47.94. This is a potential upside of $12.37 (34.78%) from yesterday's end of day stock price of $35.57.
Supernus Pharmaceuticals's activity chart (see below) currently has 63 price targets and 53 ratings on display. The stock rating distribution of SUPN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 63.92% with an average time for these price targets to be met of 271.8 days.
Highest price target for SUPN is $36, Lowest price target is $36, average price target is $47.94.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 11-Sep-2024. First documented stock forecast 12-Mar-2015.
Currently out of the existing stock ratings of SUPN, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$36
$0.43 (1.21%)
$41
2 months 7 days ago
(11-Sep-2024)
15/22 (68.18%)
$4.92 (15.83%)
130
Buy
$44
$8.43 (23.70%)
$40
2 years 11 months 17 days ago
(01-Dec-2021)
12/15 (80%)
$13.15 (42.63%)
241
Hold
$23
4 years 7 months 2 days ago
(16-Apr-2020)
5/7 (71.43%)
$1.85 (8.75%)
100
Buy
$65
$29.43 (82.74%)
$65
5 years 9 months 21 days ago
(28-Jan-2019)
2/4 (50%)
$28.85 (79.81%)
234
Buy
$57
$32.69 (134.47%)
5 years 11 months 28 days ago
(21-Nov-2018)
1/2 (50%)
$13.06 (49.50%)
654
What is SUPN (Supernus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most bullish on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most reserved on SUPN (Supernus Pharmaceuticals)?
